New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
11:14 EDTSAN, AVP, KING, PSEC, SFLY, XONE, IDIX, MDR, YRCW, INOOptions with increasing implied volatility
Options with increasing implied volatility: INO XONE KING YRCW SFLY AVP MDR PSEC SAN IDIX
News For INO;XONE;KING;YRCW;SFLY;AVP;MDR;PSEC;SAN;IDIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 15, 2015
05:48 EDTAVPStocks with implied volatility movement; WUBA AVP
Subscribe for More Information
April 14, 2015
16:53 EDTAVPOn The Fly: Top stock stories for Tuesday
Stocks on Wall Street were mixed for the day, beginning the session in positive territory helped by better than expected earnings reports from JPMorgan (JPM), Johnson & Johnson (JNJ), and Wells Fargo (WFC). The early economic data was slightly below Wall Street expectations and became a headwind for the market. By the end of the first hour of trading the market had turned negative, and it spent the remainder of the day trading in mixed fashion. ECONOMIC EVENTS: In the U.S., retail purchases for March advanced 0.9%, bouncing up from a 0.5% decline in February. However, economists had predicted a 1.1% growth after improvements on last month's weather. The producer price index grew 0.2% for March, in line with consensus estimates. Core PPI grew 0.2% versus expectations of 0.1% growth. The International Monetary Fund's World Economic Outlook Report trimmed U.S. growth forecast to 3.1% from its previous outlook of 3.6%, while global forecast was left unchanged at 3.5%. COMPANY NEWS: Avon (AVP) surged 66c, or 8.24%, to $8.67 following a Wall Street Journal report that the company is exploring strategic alternatives, including potentially selling its North American business, though a Bloomberg report later in the day claimed the company is not conducting a formal sale process... Nokia (NOK) confirmed it is in "advanced discussions" to buy French telecom firm Alcatel-Lucent (ALU), prompting French President Francois Hollande to schedule meetings with leaders from both companies. Later in the day, the French government announced it supports the potential deal, with French Economy Minister Emmanuel Macron stating Nokia reassured officials by detailing "clear undertakings." Nokia fell 34c, or 4.1%, to $7.96 at the close, while Alcatel jumped 58c, or 13.33%, to $4.93. MAJOR MOVERS: Among the notable gainers was 58.com (WUBA), which rallied 33.52%, or $17.04, to $67.87 after the Financial Times reported the company has signed a memorandum of understanding to merge with rival classifieds service Ganji.com. Also higher was PartnerRe (PRE), which advanced 8.49% to $129.25 after EXOR proposed to acquire the company for $130.00 per share in cash, valuing PartnerRe at $6.4B. Following earnings, JPMorgan (JPM) advanced 1.56% to $63.04 after beating expectations, while Wells Fargo (WFC) fell 0.73% and Johnson & Johnson fell 0.03% after reducing its FY15 earnings guidance. Among the noteworthy losers was Arrowhead Research (ARWR), which tumbled 7.75% after Jefferies downgraded the stock to Hold and lowered its price target to $9 from $30. The firm said that while ARC-520 offers the potential for a Hepatitis B virus functional cure, it prefers to wait for multi-dosing data. Also lower was Norfolk Southern (NSC), which dropped 4.18% to $100.49 and was downgraded to Hold at TD Securities following first quarter guidance that fell below expectations. INDEXES: The Dow rose 59.66, or 0.33%, to 18,036.70, the Nasdaq lost 10.96, or 0.22%%, to 4,977.29, and the S&P 500 advanced 3.41, or 0.16%, to 2,095.84.
14:45 EDTAVPAvon said not to be conducting formal sale process, Bloomberg says
12:59 EDTAVPAvon Products reviewing strategic options, WSJ reports
Subscribe for More Information
12:59 EDTAVPAvon Products volatility elevated into exploring strategic alternatives report
Avon Products overall option implied volatility of 59 compares to its 26-week average of 55 according to Track Data, suggesting large price movement into a WSJ reported the company is exploring strategic alternatives.
12:55 EDTAVPAvon Products resumes trading, shares up 74c to $8.75
Subscribe for More Information
12:55 EDTAVPAvon Products halted for volatility after jumping on WSJ report
Shares of Avon Products halted for volatility after the Wall Street Journal reported the company is exploring strategic alternatives, including a possible sale of its North America business. The stock jumped 69c to $8.70.
12:52 EDTAVPAvon Products reviewing strategic alternatives, Dow Jones says
Subscribe for More Information
10:50 EDTPSECOptions with increasing implied volatility
Subscribe for More Information
10:01 EDTMDROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:36 EDTMDRMcDermott upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital upgraded McDermott to Outperform saying the company will benefit from growing demand for offshore oil and gas construction services. The firm raised its price target for shares to $6 from $4.
April 13, 2015
17:17 EDTAVPAvon Products postpones Investor Day to fall 2015
Avon Products announced that it has decided to postpone to Fall 2015 its Investor Day that the company was originally scheduled to host on May 13. The decision to postpone the meeting follows the recent appointment of James Scully as the company's CFO, to allow the company adequate time to prepare for a more robust discussion at the meeting. Further details, including webcast information, will be announced closer to the event. Avon will provide an update on its turnaround progress when it reports first-quarter 2015 financial results on April 30.
April 12, 2015
15:56 EDTAVPAvon investors could be rewarded in coming years, Barron's says
Subscribe for More Information
April 10, 2015
16:18 EDTXONEExOne files $150M mixed securities shelf
Subscribe for More Information
April 9, 2015
10:13 EDTAVPHigh option volume stocks
Subscribe for More Information
08:08 EDTINOInovio says HPV Immunotherapy activates robust in vivo T cell responses
Inovio Pharmaceuticals announced preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in 3 of 4 patients with head and neck cancer associated with human papillomavirus (HPV) types 16 and 18. INO-3112, an active immunotherapy that targets HPV 16 and 18 and simultaneously expresses IL-12, is designed to activate in vivo immune responses to antigens from high risk HPV types and eliminate precancerous and cancerous cells displaying these antigens. The magnitude and characteristics of these interim immune response data mirror immune responses previously observed in human studies of VGX-3100 for HPV-associated cervical dysplasia; in a placebo-controlled phase II study, strong T cell immune responses were positively correlated with achievement of primary and secondary efficacy endpoints, the company said. The data, which are T cell measurements from the first four treated patients of this phase I/IIa study, are being presented today at the World Vaccine Congress 2015 by Inovio COO, Dr. Niranjan Sardesai.
April 8, 2015
19:46 EDTINOOn The Fly: After Hours Movers
UP AFTER EARNINGS: Apogee (APOG), up 6.4%... Pier 1 Imports (PIR), up 4.4%. ALSO HIGHER: Inovio Pharmaceuticals (INO), up 5.6% after being selected by DARPA to lead $45M Ebola prevention program. DOWN AFTER EARNINGS: Alcoa (AA), down 3.5%... Bed Bath & Beyond (BBBY), down 3.5%. ALSO LOWER: Zynga (ZNGA), down 10.3% after announcing CEO transition... Memorial Production (MEMP), down 2.9% after filing to sell 4.6M common units owned by MRD Holdco... Regulus (RGLS), down 2.2% after filing to sell 3.3M shares for Isis Pharmaceuticals.
09:20 EDTINOOn The Fly: Pre-market Movers
Subscribe for More Information
06:06 EDTINOInovio selected by DARPA to lead $45M Ebola prevention program
Subscribe for More Information
April 7, 2015
09:08 EDTMDRMcDermott awarded SURF installation scope for Atlanta EPS
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use